Price $249.49 |
Market Cap
48.21B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
114.7
|
P/B
18.52
|
P/S
29.18
|
Dividend %
-
|
|
P/CF
189.5
|
P/FCF
-
|
Op. Cash Flow
761.2K
|
FCF
-
|
|
Op. Margin
27.20%
|
Net Margin
25.50%
|
ROE
18.00%
|
ROI
16.00%
|
|
ROA
13.90%
|
EPS Growth
26.80%
|
Current Ratio
3.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Lannett Company, Inc. (LCI) | $1.78 | - | - | 109.5M | Strong Buy |
| Biocept Inc (BIOC) | $3.77 | - | - | 56.2M | Strong Buy |
| AmerisourceBergen Corp. (ABC) | $116.76 | - | 1.40% | 25.08B | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $6.60 | - | - | 294.7M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.40 | - | - | 93.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
